Behavioral: Agitated Patient – Adult

For pediatric and adolescent patients see, Behavioral: Agitated Patient – Pediatric or Behavioral: Agitated Patient – Adolescent

Criteria

  • This protocol is intended to be used with agitated patients requiring sedation for medical evaluation and treatment
  • This may include any patient who demonstrates potentially violent behavior, regardless of underlying etiology
  • Pharmacologic management of behavioral emergencies is only to be utilized for situations in which environmental modification and verbal de-escalation (utilizing interpersonal communication skills) is not successful or not possible
  • This protocol includes consideration for patients who are extremely combative and are at immediate risk of causing physical harm to emergency responders, the public, and/or themselves
  • See De-escalation Techniques and Altered Mental Status

All levels

  • Airway management, vital signs, and appropriate oxygen therapy, if tolerated
  • Verbal de-escalation (utilizing interpersonal communication skills)
  • If verbal de-escalation is not successful or not possible, apply soft restraints, such as towels, triangular bandages, or commercial medical restraints, only if necessary to protect the patient and others from harm

EMT and up

  • Check blood glucose level‡, as soon as you are able to safely do so. If low, see Hypoglycemia - Adult

CC and up

  • Midazolam (Versed) up to 5 mg IM or IV; may repeat up to 10 mg

Paramedic

  • Olanzapine 10 mg (2.5-5 mg if age ≥65) IMⓟ‡ once, or 5mg SLⓟ‡ once – use caution if midazolam given or anticipated
  • For patients who are extremely combative and are at immediate risk of causing physical harm to emergency responders, the public, and/or themselves who present with a clinical triad of psychomotor agitation, physiologic excitation, and failure to respond to verbal and environmental de-escalation in the setting of destructive, erratic, bizarre, or violent behavior. Common features include:
  • Unusual strength
  • Lack of tiring
  • Unnatural pain tolerance
  • Tachypnea
  • Diaphoresis
  • Psychomotor agitation
  • Tactile hyperthermia
  • Altered mental status
  • Ketamineⓟ‡ 250 mg IM
  • May administer Ketamineⓟ‡ 250 mg IM after 5 minutes (as a single repeat dose or as a single dose after Midazolam [Versed]), should the patient remain uncontrolled
  • If the agitated patient goes into cardiac arrest, refer to the appropriate protocol and Sodium Bicarbonate 50 mEq IV

Medical control

  • Midazolam (Versed) IV, IM
  • Ketamineⓟ‡ 0.5-2 mg/kg IV or IM
  • Consider initial dose of Ketamine 250 mg IM for the appropriate patient
  • Use caution ordering Ketamine after Midazolam (Versed) because apnea may occur

Key points

  • Patient must NOT be transported in a face-down position
  • Assess the scene for safety and, if it is not, retreat to a safe location and obtain police assistance
  • Utilize caution and consider smaller doses in high-risk populations such as the elderly, small patients, or those with significant comorbidities
  • Consider medical causes of abnormal behavior such as: hypoxia, hypoperfusion, hypoglycemia, head injury, intoxication, other drug ingestion, and trauma
  • Consider the possibility of a behavioral/developmental disorder such as autism spectrum disorder or mental health problems
  • Utilize waveform capnography as soon as practicable following administration of any medications in this protocol
  • A team approach should be attempted at all times for the safety of the patient and the providers
  • If the patient is in police custody and/or has handcuffs on, a police officer should accompany the patient in the ambulance to the hospital. EMS must have the ability to immediately remove any mechanical restraints that hinder patient care at all times.
  • All uses of this protocol may require Agency Medical Director review or regional QA, depending on regional procedure
Collaborative 26.2 · pp. 46–47BLS version